Curcumin is a polyphenol derived from Curcuma longa. Over the last few years, a number of
studies have provided evidence of its main pharmacological properties including …

… in cancer. Because of their exceptional tissue and tumor specificity, these regulatory RNAs
represent attractive targets for cancer therapy. … to develop lncRNA-targeted cancer therapies. …

… We focus on the emerging potential for the bench-to-bedside translation of some of these …
burgeoning evidence supporting the potential of emerging epigenetic therapies in CRC as we …

Colorectal cancer (CRC) is the third most diagnosed malignancy and the second leading
cause of cancer-related deaths worldwide. Locally advanced and metastatic disease exhibit …

Aberrant Wnt/β-catenin signaling has often been reported in different cancers, particularly
colorectal cancer (CRC), and this signaling cascade is central to carcinogenesis. …

… in many types of cancer. Here, we show that PP2A is frequently inactivated in patients
with colorectal cancer, indicating that PP2A represents a potential therapeutic target for this …

… and prospective regarding the therapeutic potential of targeting BRAF mutant colorectal …
mutant colorectal cancer, including trials and new potential approaches to targeted therapy. …

… effects, supporting the therapeutic potential of these inhibitors in … pathogenesis of CRC and
the potential clinical value of synthetic … , and hence, better management of colorectal cancer. …

… pre-clinical studies for cancer treatment. In this review, we will focus on the therapeutic role
of various CDK inhibitors in colorectal cancer, with a special focus on the CDK4/6 inhibitors. …

… its potential value as a therapeutic target in … therapeutic potential of targeting Wnt pathway
with particular emphasis on preclinical/clinical studies in treatment of colorectal cancer…